Results 91 to 100 of about 406,081 (396)

Electrical cardioversion of atrial arrhythmias with cardiac amyloidosis in the era of direct oral anticogulants

ESC Heart Failure, 2022
Aims Atrial fibrillation (AF)/atrial flutter is common during cardiac amyloidosis (CA). Electrical cardioversion (EC) is a strategy to restore sinus rhythm (SR). However, left atrial thrombus (LAT) represents a contraindication for EC.
Olivier Touboul, Vincent Algalarrondo, Silvia Oghina, Nathalie Elbaz, Segolene Rouffiac, David Hamon, Fabrice Extramiana, Estelle Gandjbakhch, Thomas D'Humieres, Eloi Marijon, Tarvinder S. Dhanjal, Emmanuel Teiger, Thibaud Damy, Nicolas Lellouche   +13 more
doaj   +1 more source

Considerations for drug trials in hypertrophic cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 1095-1112, April 2025.
Abstract Hypertrophic cardiomyopathy (HCM) is a heterogeneous condition with potentially serious manifestations. Management has traditionally comprised therapies to palliate symptoms and implantable cardioverter‐defibrillators to prevent sudden cardiac death. The need for disease‐modifying therapies has been recognized for decades.
John P. Farrant, Matthias Schmitt, Anna B. Reid, Clifford J. Garratt, William G. Newman, Aneil Malhotra, Rhys Beynon, Masliza Mahmod, Betty Raman, Robert M. Cooper, Dana Dawson, Thomas Green, Sanjay K. Prasad, Anvesha Singh, Susanna Dodd, Hugh Watkins, Stefan Neubauer, Christopher A. Miller   +17 more
wiley   +1 more source

Advanced ablation strategies for management of post-surgical atrial arrhythmias. [PDF]

, 2013
Post-surgical arrhythmias include a wide range of arrhythmias occurring late after cardiac surgery and represent a complex substrate for catheter ablation either because of extended scar and remodeling or because of limited access to the area of interest.
Babu-Narayan, SV, Ernst, S, Mantziari, L, Suman-Horduna, I   +3 more
core   +1 more source

Association of BMI with adherence and outcome in heart failure patients treated with wearable cardioverter defibrillator

ESC Heart Failure, Volume 12, Issue 2, Page 1295-1303, April 2025.
Abstract Background Obesity is a known risk factor for cardiovascular disease (CVD), yet an ‘obesity paradox’ has been observed in various CVD contexts. The impact of obesity on heart failure (HF) patients treated with a wearable cardioverter‐defibrillator (WCD) remains underexplored.
Mohammad Abumayyaleh, Katharina Koepsel, Julia W. Erath, Thomas Kuntz, Norbert Klein, Boldizsar Kovacs, Firat Duru, Ardan M. Saguner, Christian Blockhaus, Dong‐In Shin, Fabienne Kreimer, Michael Gotzmann, Hendrik Lapp, Thomas Beiert, Assem Aweimer, Andreas Mügge, Christel Weiß, Ibrahim El‐Battrawy, Ibrahim Akin   +18 more
wiley   +1 more source

Pharmacological cardioversion for atrial fibrillation and flutter.

Cochrane Database of Systematic Reviews, 2017
BACKGROUND Atrial fibrillation is the commonest cardiac dysrhythmia. It is associated with significant morbidity and mortality. There are two approaches to the management of atrial fibrillation: controlling the ventricular rate or converting to sinus ...
J. Cordina, G. Mead
semanticscholar   +1 more source

Long-term results of catheter radiofrequency ablation of cavotricuspid isthmus in patients with typical atrial flutter and diabetes mellitus type 2

RUDN Journal of Medicine, 2016
Aim - to evaluate the effectiveness of radiofrequency ablation cavotricuspid of the isthmus in patients with diabetes mellitus (DM) type 2, and typical atrial flutter, as well as to identify the factors of recurrence of atrial flutter after the procedure.
Yu A Kachanova, N A Novikova, A L Syrkin
doaj  

Body mass index, abdominal fatness, fat mass and the risk of atrial fibrillation: a systematic review and dose–response meta-analysis of prospective studies [PDF]

, 2017
Different adiposity measures have been associ- ated with increased risk of atrial fibrillation, however, results have previously only been summarized for BMI. We therefore conducted a systematic review and meta- analysis of prospective studies to clarify
Aune, D, Janszky, I, Norat, T, Riboli, E, Romundstad, P, Schlesinger, S, Sen, A, Tonstad, S, Vattan, LJ   +8 more
core   +1 more source

Left atrial function in uraemic patients: Four‐dimensional automatic left atrial quantitative technology study

ESC Heart Failure, Volume 12, Issue 2, Page 1316-1325, April 2025.
Abstract Objective This study aimed to evaluate the utility of left atrial volume and function in uraemic patients using four‐dimensional automatic left atrial quantification (4D auto LAQ) technology. Methods Thirty‐four undialysed uraemic patients (U‐ND group), 60 dialysed uraemic patients (U‐D group), and 32 healthy volunteers (N group) were enrolled
Bing Li, Meihua Chen, Xuning Huang
wiley   +1 more source

A novel approach to terminate roof-dependent atrial flutter with epicardial conduction through septopulmonary bundle

BMC Cardiovascular Disorders
Atrial flutter, a prevalent cardiac arrhythmia, is primarily characterized by reentrant circuits in the right atrium. However, atypical forms of atrial flutter present distinct challenges in terms of diagnosis and treatment.
Dongchen Zhou, Biqi Zhang, Cong Zeng, Xiang Yin, Xiaogang Guo   +4 more
doaj   +1 more source

Preventing atrial fibrillation by combined right isthmus ablation and cryoballoon pulmonary vein isolation in patients with typical atrial flutter: PAF‐CRIOBLAF study

Journal of Arrhythmia, 2021
Background Although less common, typical atrial flutter shares similar pathophysiological roots with atrial fibrillation. Following successful cavo‐tricuspid isthmus ablation using radiofrequency, many patients, however, develop atrial fibrillation in ...
Frédéric Anselme, Arnaud Savouré, Nicolas Clémenty, Olivier Cesari, Dominique Pavin, Laurence Jesel, Pascal Defaye, Serge Boveda, Philippe Rivat, Jacques Mansourati, Alexis Mechulan, Jean‐Pierre Cebron, Gilles Lande, Michael Bubenheim ScD, Antoine Milhem   +14 more
doaj   +1 more source